Phase 2CompletedAge-related condition

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)

National, Multicentre, Randomized, Double-blind, Double-dummy Phase II Clinical Trial to Evaluate the Efficacy and Safety of S (+) - Ibuprofen for Pain Control in Individuals With Osteoarthritis

Sponsor
Apsen Farmaceutica S.A. (Industry)
Enrollment
176 enrolled
Conditions
Osteoarthritis
Interventions
S (+) - Ibuprofen; Ibuvix® - ibuprofen
Ages
adults, older adults
Registry
NCT04637529

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to evaluate the efficacy of S (+) - ibuprofen compared to an active treatment for pain control in individuals diagnosed with osteoarthritis.

Primary outcomes

  • Mean reduction of pain measured by the WOMAC Osteoarthritis Index (pain)

History

  1. Last registry update

  2. Primary completion

  3. Started

  4. Registered